Post-approval studies (Phase 4)Study completedNCT00219219
What this trial is testing
Zoledronic Acid in the Prevention of Skeletal-related Events in Hormone Refractory and Hormone-sensitive Prostate Cancer Patients With Bone Metastases
Who this might be right for
Prostate Cancer
Novartis